DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
48. 原発性抗リン脂質抗体症候群
Primary antiphospholipid syndrome
Clinical trials
/
Disease details
臨床試験数
:
5
/
薬物数
:
6
- (
DrugBank
:
4
) /
標的遺伝子数
:
1
-
標的パスウェイ数
:
7
Search
1 trial found
10
50
100
ALL
diseases per page:
Showing 1 to 1 of 1 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT05671757
(
ClinicalTrials.gov
)
March 12, 2023
20/12/2022
Daratumumab
in Primary Antiphospholipid Syndrome
Targeting CD38 With
Daratumumab
in Primary Antiphospholipid Syndrome: A Phase 1b Dose Escalation Safety Trial (ITN093AI)
Targeting CD38 With
Daratumumab
in Primary Antiphospholipid Syndrome: A Phase 1b Dose Escalation Safe ...
Autoimmune Disorders
Biological:
Daratumumab
National Institute of Allergy and Infectious Diseases (NIAID)
Immune Tolerance Network (ITN);PPD;Rho Federal Systems Division, Inc.
Not yet recruiting
18 Years
65 Years
All
22
Phase 1/Phase 2
United States